Cargando…

Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study

BACKGROUND: Methotrexate monotherapy is recommended as a maintenance therapy for Crohn’s disease (CD). However, long-term follow-up data are scarce. OBJECTIVES: We aimed to examine the effectiveness and tolerability of methotrexate monotherapy in 94 CD patients from three inflammatory bowel disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jihye, Chun, Jaeyoung, Park, Soo Jung, Park, Jae Jun, Kim, Tae Il, Yoon, Hyuk, Cheon, Jae Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467270/ https://www.ncbi.nlm.nih.gov/pubmed/37655055 http://dx.doi.org/10.1177/17562848231191664

Ejemplares similares

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
por: Park, Jihye, et al.
Publicado: (2018)

Short-term tolerability and effectiveness of methotrexate monotherapy in adult patients with Crohn’s disease: a retrospective study
por: Hong, Hee Seung, et al.
Publicado: (2021)

Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
por: Hyun, Hye Kyung, et al.
Publicado: (2022)

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
por: Yu, Jongwook, et al.
Publicado: (2022)

Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years
por: Yoon, Jin Young, et al.
Publicado: (2018)

Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
por: Hyun, Hye Kyung, et al.
Publicado: (2022)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
por: Kwak, Min Seob, et al.
Publicado: (2018)

Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study
por: Kim, Yuna, et al.
Publicado: (2022)

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
por: Sohn, Il Woong, et al.
Publicado: (2016)

Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis
por: Jang, Jihun, et al.
Publicado: (2023)

Magnetic resonance enterography predicts the prognosis of Crohn's disease
por: Lee, Ji Hoon, et al.
Publicado: (2018)

Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
por: Kwak, Min Seob, et al.
Publicado: (2014)

Impact of early anti-TNF use on clinical outcomes in Crohn’s disease: a nationwide population-based study
por: Jung, Yoon Suk, et al.
Publicado: (2020)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
por: Jung, Yoon Suk, et al.
Publicado: (2021)

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
por: Yu, Jongwook, et al.
Publicado: (2021)

Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence
por: Park, Jihye, et al.
Publicado: (2018)

Clinical Outcomes and Predictive Factors for Response after the First Course of Corticosteroid Therapy in Patients with Crohn's Disease
por: Kim, Duk Hwan, et al.
Publicado: (2013)

Methotrexate showed efficacy both in Crohn’s disease and ulcerative colitis, predictors of surgery were identified in patients initially treated with methotrexate monotherapy
por: Wang, Mengyao, et al.
Publicado: (2022)

Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid
por: Wojtczak, Magdalena, et al.
Publicado: (2023)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Metronidazole-induced encephalopathy in a patient with Crohn's disease
por: Kim, Jihye, et al.
Publicado: (2017)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
por: Park, Jihye, et al.
Publicado: (2018)

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
por: Park, Jihye, et al.
Publicado: (2017)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Incidence and Prevalence of Inflammatory Bowel Disease across Asia
por: Park, Jihye, et al.
Publicado: (2021)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022)

Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
por: Taylor, Peter C., et al.
Publicado: (2022)

Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea
por: Cheon, Jae Hee, et al.
Publicado: (2014)

Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
por: Choi, Chang Hwan, et al.
Publicado: (2016)

Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
por: Park, Yong Eun, et al.
Publicado: (2021)

Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease
por: Kim, Sung Bae, et al.
Publicado: (2020)

Association of Family History With Cancer Recurrence, Survival, and the Incidence of Colorectal Adenoma in Patients With Colorectal Cancer
por: Park, Yehyun, et al.
Publicado: (2019)

Second Korean guidelines for the management of Crohn's disease
por: Park, Jae Jun, et al.
Publicado: (2017)

Identification of OCTN2 variants and their association with phenotypes of Crohn’s disease in a Korean population
por: Park, Hyo Jin, et al.
Publicado: (2016)

The Common and Unique Pattern of Microbiome Profiles among Saliva, Tissue, and Stool Samples in Patients with Crohn’s Disease
por: Shin, Seung Yong, et al.
Publicado: (2022)

Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
por: Park, Jihye, et al.
Publicado: (2021)

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet’s Disease
por: Park, Jung Won, et al.
Publicado: (2018)

Probe-based confocal laser endomicroscopy in the differential diagnosis of inflammatory bowel diseases: a case series
por: Park, Jung Won, et al.
Publicado: (2018)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
por: Lee, Yong Il, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_43bbg1258osbtf7oujiac1ck7g